KALOBIOS PHARMACEUTICALS INC's ticker is KBIO and the CUSIP is 48344T100. A total of 18 filers reported holding KALOBIOS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $35,000 | -66.7% | 72,507 | +18.7% | 0.02% | -63.1% |
| Q4 2014 | $105,000 | +15.4% | 61,089 | +3.3% | 0.06% | +14.0% |
| Q3 2014 | $91,000 | -32.1% | 59,140 | +0.5% | 0.06% | -28.8% |
| Q2 2014 | $134,000 | -13.5% | 58,838 | +2.4% | 0.08% | -16.7% |
| Q1 2014 | $155,000 | -38.2% | 57,487 | +1.0% | 0.10% | -36.8% |
| Q4 2013 | $251,000 | +2.0% | 56,925 | +4.4% | 0.15% | +29.9% |
| Q3 2013 | $246,000 | – | 54,517 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 545,000 | $1,474,000 | 1.09% |
| GREAT POINT PARTNERS LLC | 536,894 | $1,455,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,786,783 | $7,552,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 360,000 | $976,000 | 0.22% |
| WALL STREET ASSOCIATES | 611,300 | $1,657,000 | 0.14% |
| Old West Investment Management, LLC | 57,487 | $155,000 | 0.10% |
| WEXFORD CAPITAL LP | 312,493 | $847,000 | 0.06% |
| CLOUGH CAPITAL PARTNERS L P | 402,000 | $1,089,000 | 0.03% |
| SSI INVESTMENT MANAGEMENT LLC | 73,870 | $200,000 | 0.02% |
| PRIMECAP MANAGEMENT CO/CA/ | 4,691,475 | $12,714,000 | 0.01% |